Literature DB >> 28629926

Different functional susceptibilities of mouse retinal ganglion cell subtypes to optic nerve crush injury.

Zhen Puyang1, Hai-Qing Gong1, Shi-Gang He1, John B Troy2, Xiaorong Liu3, Pei-Ji Liang4.   

Abstract

In optic neuropathies, the progressive deterioration of retinal ganglion cell (RGC) function leads to irreversible vision loss. Increasing experimental evidence suggests differing susceptibility for RGC functional subtypes. Here with multi-electrode array recordings, RGC functional loss was characterized at multiple time points in a mouse model of optic nerve crush. Firing rate, latency of response and receptive field size were analyzed for ON, OFF and ON-OFF RGCs separately. It was observed that responses and receptive fields of OFF cells were impaired earlier than ON cells after the injury. For the ON-OFF cells, the OFF component of response was also more susceptible to optic nerve injury than the ON component. Moreover, more ON transient cells survived than ON sustained cells post the crush, implying a diversified vulnerability for ON cells. Together, these data support the contention that RGCs' functional degeneration in optic nerve injury is subtype dependent, a fact that needs to be considered when developing treatments of glaucomatous retinal ganglion cell degeneration and other optic neuropathies.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Multi-electrode array recording; Optic nerve crush; Retinal ganglion cells (RGCs); Subtype-dependent degeneration

Mesh:

Year:  2017        PMID: 28629926     DOI: 10.1016/j.exer.2017.06.014

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  18 in total

1.  Improving visible light OCT of the human retina with rapid spectral shaping and axial tracking.

Authors:  Tingwei Zhang; Aaron M Kho; Vivek J Srinivasan
Journal:  Biomed Opt Express       Date:  2019-05-21       Impact factor: 3.732

2.  Correlation between retinal ganglion cell loss and nerve crush force-impulse established with instrumented tweezers in mice.

Authors:  Xiaorong Liu; Liang Feng; Ishan Shinde; James D Cole; John B Troy; Laxman Saggere
Journal:  Neurol Res       Date:  2020-02-26       Impact factor: 2.448

3.  Effect of ocular hypertension on the pattern of retinal ganglion cell subtype loss in a mouse model of early-onset glaucoma.

Authors:  S Daniel; K J Meyer; A F Clark; M G Anderson; C M McDowell
Journal:  Exp Eye Res       Date:  2019-06-15       Impact factor: 3.467

Review 4.  Differential susceptibility of retinal ganglion cell subtypes against neurodegenerative diseases.

Authors:  Ningzhi Zhang; Xuejun He; Yiqiao Xing; Ning Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-17       Impact factor: 3.117

5.  Asymmetric Functional Impairment of ON and OFF Retinal Pathways in Glaucoma.

Authors:  Alan W Kong; Marcus L Turner; Hoover Chan; Robert L Stamper; Benjamin F Arnold; Luca Della Santina; Yvonne Ou
Journal:  Ophthalmol Sci       Date:  2021-05-10

6.  Preferential Loss of Contrast Decrement Responses in Human Glaucoma.

Authors:  Anthony M Norcia; Alexandra Yakovleva; Naz Jehangir; Jeffrey L Goldberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-10-03       Impact factor: 4.925

Review 7.  Advances in the Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells.

Authors:  Sarah K Ohlemacher; Kirstin B Langer; Clarisse M Fligor; Elyse M Feder; Michael C Edler; Jason S Meyer
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

8.  Retinal Ganglion Cell Diversity and Subtype Specification from Human Pluripotent Stem Cells.

Authors:  Kirstin B Langer; Sarah K Ohlemacher; M Joseph Phillips; Clarisse M Fligor; Peng Jiang; David M Gamm; Jason S Meyer
Journal:  Stem Cell Reports       Date:  2018-03-22       Impact factor: 7.765

Review 9.  Discovery and clinical translation of novel glaucoma biomarkers.

Authors:  Gala Beykin; Anthony M Norcia; Vivek J Srinivasan; Alfredo Dubra; Jeffrey L Goldberg
Journal:  Prog Retin Eye Res       Date:  2020-07-10       Impact factor: 21.198

Review 10.  Regenerative medicine in the retina: from stem cells to cell replacement therapy.

Authors:  Julia Oswald; Petr Baranov
Journal:  Ther Adv Ophthalmol       Date:  2018-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.